These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 215511)

  • 1. Histological types of nasopharyngeal carcinoma in an intermediate risk area.
    Cammoun M; Ellouz R; Behi J; Attia RB
    IARC Sci Publ (1971); 1978; (20):13-26. PubMed ID: 215511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological types of nasopharyngeal carcinoma in a low-risk area: Japan.
    Sugano H; Sakamoto G; Sawaki S; Hirayama T
    IARC Sci Publ (1971); 1978; (20):27-39. PubMed ID: 215515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological typing of nasopharyngeal carcinoma.
    Shanmugaratnam K
    IARC Sci Publ (1971); 1978; (20):3-12. PubMed ID: 215516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological types of nasopharyngeal carcinoma as compared to EBV serology.
    Krueger GR; Kottaridis SD; Wolf H; Ablashi DV; Sesterhenn K; Bertram G
    Anticancer Res; 1981; 1(4):187-94. PubMed ID: 6285799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
    Henle W; Henle G; Ho JH
    IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
    [No Abstract]   [Full Text] [Related]  

  • 6. Nasopharyngeal carcinoma in children and adolescents in Tunisia: clinical aspects and the paraneoplastic syndrome.
    Ellouz R; Cammoun M; Attia RB; Bahi J
    IARC Sci Publ (1971); 1978; (20):115-29. PubMed ID: 730188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of immunological studies in evaluating the clinical course of nasopharyngeal carcinoma.
    Sawaki S; Kawamura A; Tachibana T
    IARC Sci Publ (1971); 1978; (20):575-85. PubMed ID: 215534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects and natural history of nasopharyngeal carcinoma in Western Europe.
    Cachin Y; Schwaab G; Sancho-Garnier H; Marandas P
    IARC Sci Publ (1971); 1978; (20):131-45. PubMed ID: 215512
    [No Abstract]   [Full Text] [Related]  

  • 9. Stage classification of nasopharyngeal carcinoma: a review.
    Ho JH
    IARC Sci Publ (1971); 1978; (20):99-113. PubMed ID: 365707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of EBV serology in American patients with nasopharyngeal carcinoma.
    Pearson GR; Coates HL; Neel HB; Levine P; Ablashi D; Easton J
    IARC Sci Publ (1971); 1978; (20):439-48. PubMed ID: 215526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinomas of the nasopharynx. Relationship between histological type and anti-Epstein-Barr virus serology (author's transl)].
    Micheau C; de The G; Orofiamma B; Schwaab G; Brugere J; Tursz T; Sancho-Garnier H; Cachin Y
    Nouv Presse Med; 1980 Jan; 9(1):21-4. PubMed ID: 6243770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Epstein Barr virus antibody in nasopharyngeal carcinoma.
    Hsu MM; Chiou JF; McCabe BF
    Ann Otol Rhinol Laryngol; 1974; 83(1):19-25. PubMed ID: 4359674
    [No Abstract]   [Full Text] [Related]  

  • 14. Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.
    Henle W; Ho JH; Henle G; Chau JC; Kwan HC
    Int J Cancer; 1977 Nov; 20(5):663-72. PubMed ID: 200569
    [No Abstract]   [Full Text] [Related]  

  • 15. Squamous carcinoma of the nasopharynx.
    Moloy PJ; Chung YT; Krivitsky PB; Kim RC
    West J Med; 1985 Jul; 143(1):66-9. PubMed ID: 2994305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of Epstein-Barr virus serology during radiotherapy of undifferentiated carcinoma of the nasopharynx].
    Yomi J; Fouda A; Fossi A; Bejanga B
    Bull Cancer Radiother; 1996; 83(3):168-9. PubMed ID: 8977568
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
    Caliceti U; Cevenini R; Donati M
    Acta Otorhinolaryngol Ital; 1985; 5(1):83-90. PubMed ID: 2994355
    [No Abstract]   [Full Text] [Related]  

  • 18. Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody.
    Lynn T; Tu S; Hirayama T; Kawamura A
    Jpn J Exp Med; 1973 Apr; 43(2):135-44. PubMed ID: 4352112
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance.
    Gallo O; Bianchi S; Giannini A; Gallina E; Libonati GA; Fini-Storchi O
    Laryngoscope; 1991 May; 101(5):487-93. PubMed ID: 2030628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective evaluation of patients with nasopharyngeal carcinoma: an overview.
    Neel HB
    J Otolaryngol; 1986 Jun; 15(3):137-44. PubMed ID: 3014165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.